Porges A J, Beattie S L, Ritchlin C, Kimberly R P, Christian C L
Division of Rheumatology, Hospital for Special Surgery, Cornell University Medical College, New York, NY 10021.
J Rheumatol. 1992 Aug;19(8):1191-4.
We describe 6 cases of patients with systemic lupus erythematosus (SLE) who developed Pneumocystis carinii pneumonia. All were treated with high dose corticosteroids, and all developed the infection within 4 months of beginning new or revised cytotoxic therapy. All patients tested (5 of 6) were negative for human immunodeficiency virus (HIV). Those patients who developed Pneumocystis carinii pneumonia had more severe lymphocytopenia (median 595 vs 833/mm3) and received higher doses of corticosteroids (median prednisone dose = 43 vs 20 mg/day) than other patients with active SLE. A threshold lymphocyte count of 350/mm3 identified 4 of 6 cases but only 1 of 20 controls. Patients with SLE treated with high dose corticosteroids and cytotoxic drugs and with severe lymphocytopenia may be at increased risk for this opportunistic infection.
我们描述了6例系统性红斑狼疮(SLE)患者发生卡氏肺孢子虫肺炎的情况。所有患者均接受了大剂量皮质类固醇治疗,且均在开始新的或修订的细胞毒性治疗后4个月内发生感染。所有接受检测的患者(6例中的5例)人类免疫缺陷病毒(HIV)检测均为阴性。发生卡氏肺孢子虫肺炎的患者淋巴细胞减少更为严重(中位数为595 vs 833/mm³),且比其他活动性SLE患者接受了更高剂量的皮质类固醇治疗(泼尼松剂量中位数 = 43 vs 20 mg/天)。淋巴细胞计数阈值为350/mm³可识别出6例中的4例,但20例对照中仅1例。接受大剂量皮质类固醇和细胞毒性药物治疗且淋巴细胞严重减少的SLE患者发生这种机会性感染的风险可能会增加。